Join us at the upcoming #OCRA Annual Conference on August 2 and listen to Abie Ekangaki, PhD discuss how #insilico methods can help accelerate drug development! https://bit.ly/3LBtrpe
Premier Research’s Post
More Relevant Posts
-
TRANSFEROSOMES – A NOVEL DRUG DELIVERY SYSTEM: A REVIEW https://lnkd.in/gqNdHezQ
-
-
In this article with Drug Development & Delivery, Dr. Paul Quigley, Principal Research Fellow of Drug Substance, shares insight on the trends that will have the most impact on #drugdevelopment in 2024. Read the full article here: https://bit.ly/3vWjnCL
-
-
Check out this Methodology published in Bioanalysis, which describes a free new tool, BiSim, that supports drug development for all patients worldwide: https://bit.ly/4c6PeRA
-
Our latest article highlights how cell line development has evolved over the years. Learn about the new solutions like single-cell, gene-editing, and automation that address the field's major challenges and enable efficacious drug development. https://lnkd.in/ePMx-4E6
-
-
Head of AI/ML for Drug R&D 💡- Bridging Science 🧠, Data 📊, and Technology (AI) 🤖 to Help Life Sciences Companies Bring Better Products 💊 to Market Faster
"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons" A paper from the Boston Consulting Group (BCG) published in Elsevier's Drug Discovery Today As far as i know, this is the first paper looking (holistically) at "AI-developed" drug vs drugs developed using a traditional workflow. 🌟 "In Phase I we find AI-discovered molecules have an 80–90% success rate" -> much higher than industry average 🌟 "In Phase II the success rate is $40%, albeit on a limited sample size, comparable to historic industry averages" It's still too early to judge, but it's good to have this paper to clarify what are the metrics as of 2024
-
Day 3: Project on drug analysis is about 80% done 🥁🥁🥁. Tomorrow for the full description of the project including the report and Recommendations. #amdari21daysdatachallenge #ultimateDataGrasp #Nigeriandataanalyst #ExcelforanalysisDay 3: Project on drug analysis is about 80% done 🥁🥁🥁. Tomorrow for the full description of the project including the report and Recommendation. #amdari21daysdatachallenge #ultimateDataGrasp #Nigeriandataanalyst #Excelforanalysis
-
In our latest #blog, Dr. Richard Castledine, Head of Drug Substance and Translational Pharmaceutics Operations, speaks on some of the main considerations that drug developers and their partners face in #drugsubstance API synthesis. Check it out here: https://bit.ly/3TxR6LL
-
-
𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗼𝗳 𝗧𝗵𝗲 𝗪𝗲𝗲𝗸! “What do you see as the sources of insight and creativity that will drive the next generation of drug development?” Comment Below or Answer Here: https://hubs.la/Q02zyvQD0 #SurfingMASH #MASLD #QuestionOfTheWeek
-
-
#ICYMI: Last month, we had a busy few days at the NextGen Conference. As the pioneer of #suprachoroidal delivery, our own Viral Kansara, PhD ran several key discussions around suprachoroidal drug administration: - Led a Workshop: "Exploring Latest Development in Suprachoroidal Delivery" - Chaired the 1st Day of the Conference - Led the Roundtable discussion: "Brainstorming Benefit-Risk Considerations for Novel #Ophthalmic Delivery Technology & Combination Products" More: https://lnkd.in/eUAQgfb3
-
-
Do you understand optimal design of experiments? If not, this is your chance to learn how to make the most of your available resources when designing clinical trials. #optimaldesign #clinicaltrials #paediatrics #rarediseases #pharmacometrics #pharma
📣 New Tutorial: Introduction to Optimal Design 📣 Easily optimize your experimental designs to learn as much as possible about your model's parameters of interest with as little data as possible, ex. in pediatric or rare disease trials. In this tutorial, you can learn about the theory and practice of optimal design with complete code examples using Pumas to help you design more ethical and more economical experiments. https://lnkd.in/dawFSE4n #pumas #optimaldesign #simulation #julialang #pharma #biotech
-
Felix Perez, CEO Research Director
2moExciting topic! Looking forward to gaining insights from Abie Ekangaki on accelerating drug development through insilico methods at the OCRA Annual Conference.